Drug Delivery: Surveying the Global Competitive Landscape

  • March 2013
  • -
  • Espicom Business Intelligence
  • -
  • 702 pages

Drug Delivery:Surveying the Global Competitive Landscape

Drug Delivery: Surveying the global competitive landscape is a new (March 2013) richly-detailed report which examines, in depth, 106 leading and emerging specialist drug delivery companies. The report covers all major technology areas including controlled-release, nucleic acid, nano-enabled and targeted delivery.

The importance of drug-delivery technology grows ever more apparent and commercial and pharma industry interest continues to build. The new biologic products which are coming to market are widening the demand for novel delivery targeted mechanisms. Controlled-release technologies continue to play a crucial role in a product’s life-cycle and the pharma industry is able to extend patent protection and preserve revenues.

The emerging biosimilars market offers great potential for developers of targeted delivery as a range of high-value brands such as Roche’s Herceptin and Avastin will be subject to patent challenges in the coming years. With many biosimilars planned or already in development around the world, the need for novel delivery mechanisms will increase.

This report provides you with key data for each company...

Company Overview & Technology Focus
Key Personnel
Key Milestones
Products/Technologies
Research Activities
Key Agreements & Alliances
Financial Data (where available)
Contact Details

The ability to readily assess the companies involved, compare areas of research interest, profile products being developed, identify strategic collaborations and evaluate performance/funding is key to understanding this market. In 716 information-packed pages, this new report Drug Delivery: Surveying the global competitive landscape (published March 2013) evaluates companies large and small from multinationals to specialist development and technology organisations.

Related Publications

Drug Delivery Insight
Whether your interest is commercial, financial, scientific or technological, no other business publication comes close to Drug Delivery Insight for providing such a comprehensive overview of the latest developments in every area of drug delivery. Available in print or updated regularly online.

Emerging Drug Delivery Technologies & Strategies: Players, Pipelines and Partnerships
This 3-volume 185-page report is essential for commercial business analysts, research planners and new product development specialists. Anyone who needs to understand the future outlook for, and competitive environment in, the global drug delivery market will benefit.

Drug Delivery Technologies: Advanced Oral & Parenteral
This major 2-volume report is essential reading for everyone in the drug delivery field, from niche technology specialists in the investment community and the pharmaceutical industry.

Medical Device Companies Analysis
A unique reporting service providing a complete appraisal of leading medical device companies worldwide, from 5-year financial review to analysis of significant strategic alliances and research portfolios.

This report details some of the most exciting technology out there and the companies involved

Web access included at no additional cost!

Analysis of 106 companies including...

3M Drug Delivery Systems
Access Pharmaceuticals Inc
Acrux Ltd
Acura Pharmaceuticals
Agile Therapeutics
Alkermes Inc
Allergy Therapeutics
Aradigm Corporation
Atlantic Pharmaceuticals
Baxa Corporation
Baxter International Inc
Biosante Pharmaceuticals Inc
Calando Pharmaceuticals
Camurus AB
Cell Therapeutics Inc
Cephalon
Debiopharm SA
Delcath Systems Inc
Depomed Inc
Durect Corporation
DUSA Pharmaceuticals Inc
Echo Therapeutics
Emisphere Technologies Inc
Enzon Inc
Ethypharm S/A
Flamel Technologies Inc
GenVec
Gilead Sciences
Hospira
Immunogen
Impax Laboratories
Innocoll Technologies
Inovio Pharmaceuticals
InSite Vision Inc
Intercell AG
Light Sciences Oncology
Mannkind Corporation
Marina Biotech
MedImmune Inc
Moog Medical Devices
Nanobiotix
Nanotherapeutics Inc
Nektar Therapeutics
NovaDel Pharma
Orexo
Otsuka Holdings
Pearl Therapeutics
Phosphagenics Limited
PolyTherics Ltd
Seattle Genetics
Skinvisible Inc
SkyePharma Plc
Soligenix
Starpharma
Tekmira Pharmaceuticals Corporation
Unilife
Valeant Pharmaceuticals
Vectura Ltd
Vical Inc
Vivus Inc
Zogenix Inc
Zosano Pharma

Table Of Contents

CONTENTS

3M DRUG DELIVERY SYSTEMS 1
KEY PERSONNEL .1
COMPANY OVERVIEW 1
KEY MILESTONES 1
PRODUCTS / TECHNOLOGIES .2
AGREEMENTS 6
KEY FINANCIAL DATA 7
COMPETITION 7

ACCESS PHARMACEUTICALS INC 9
KEY PERSONNEL .9
COMPANY OVERVIEW 9
KEY MILESTONES 9
PRODUCTS / TECHNOLOGIES 10
RESEARCH ACTIVITIES .12
AGREEMENTS .15
KEY FINANCIAL DATA 17
COMPETITION 17

ACRUX LTD 19
KEY PERSONNEL 19
COMPANY OVERVIEW .19
KEY MILESTONES 19
PRODUCTS / TECHNOLOGIES 20
RESEARCH ACTIVITIES .21
AGREEMENTS .22
KEY FINANCIAL DATA 22

ACURA PHARMACEUTICALS 23
KEY PERSONNEL 23
COMPANY OVERVIEW .23
KEY MILESTONES 23
PRODUCTS / TECHNOLOGIES 23
RESEARCH ACTIVITIES .25
AGREEMENTS .26
KEY FINANCIAL DATA 27
COMPETITION 27

AGILE THERAPEUTICS 29
KEY PERSONNEL 29
COMPANY OVERVIEW .29
PRODUCTS / TECHNOLOGIES 29
RESEARCH ACTIVITIES .30
KEY FINANCIAL DATA 31
COMPETITION 31

ALKERMES INC 33
KEY PERSONNEL 33
COMPANY OVERVIEW .33
KEY MILESTONES 33
PRODUCTS / TECHNOLOGIES .34
PRODUCTS / TECHNOLOGIES (Elan Drug Technologies) 36
RESEARCH ACTIVITIES 39
AGREEMENTS .45
KEY FINANCIAL DATA 46
COMPETITION 46

ALLERGY THERAPEUTICS 47
KEY PERSONNEL .47
COMPANY OVERVIEW 47
KEY MILESTONES 47
PRODUCTS / TECHNOLOGIES .48
RESEARCH ACTIVITIES 50
AGREEMENTS 50
KEY FINANCIAL DATA 51
COMPETITION 51

APRICUS BIOSCIENCES INC 53
KEY PERSONNEL .53
COMPANY OVERVIEW 53
KEY MILESTONES 53
PRODUCTS / TECHNOLOGIES .54
RESEARCH ACTIVITIES 55
AGREEMENTS 57
KEY FINANCIAL DATA 58
COMPETITION 59

APTALIS PHARMA 61
KEY PERSONNEL .61
COMPANY OVERVIEW 61
KEY MILESTONES 61
PRODUCTS / TECHNOLOGIES .62
AGREEMENTS 65
KEY FINANCIAL DATA 65

APTARGROUP .67
KEY PERSONNEL .67
COMPANY OVERVIEW 67
KEY MILESTONES 67
PRODUCTS / TECHNOLOGIES .67
KEY FINANCIAL DATA 68
COMPETITION 68

ARADIGM CORPORATION 69
KEY PERSONNEL .69
COMPANY OVERVIEW 69
KEY MILESTONES 69
PRODUCTS / TECHNOLOGIES .70
RESEARCH ACTIVITIES 71
AGREEMENTS 72
KEY FINANCIAL DATA 72
COMPETITION 73

ATLANTIC PHARMACEUTICALS 75
KEY PERSONNEL .75
COMPANY OVERVIEW 75
KEY MILESTONES 75
PRODUCTS / TECHNOLOGIES .75
KEY FINANCIAL DATA 76
COMPETITION 76

BAXTER INTERNATIONAL INC 77
KEY PERSONNEL .77
COMPANY OVERVIEW 77
KEY MILESTONES 77
PRODUCTS / TECHNOLOGIES .78
RESEARCH ACTIVITIES 86
AGREEMENTS 87
KEY FINANCIAL DATA 88
COMPETITION 88

BIND BIOSCIENCES 89
KEY PERSONNEL .89
COMPANY OVERVIEW 89
PRODUCTS / TECHNOLOGIES .89
RESEARCH ACTIVITIES 90
AGREEMENTS 91
KEY FINANCIAL DATA 91
COMPETITION 91

BIODELIVERY SCIENCES INTERNATIONAL 93
KEY PERSONNEL .93
COMPANY OVERVIEW 93
KEY MILESTONES 93
PRODUCTS / TECHNOLOGIES .94
RESEARCH ACTIVITIES 97
AGREEMENTS 97
KEY FINANCIAL DATA 98
ASSOCIATED COMPANIES 99
COMPETITION 99

BIOJECT MEDICAL TECHNOLOGIES INC 101
KEY PERSONNEL 101
COMPANY OVERVIEW .101
KEY MILESTONE 101
PRODUCTS / TECHNOLOGIES 101
RESEARCH ACTIVITIES .103
AGREEMENTS .104
KEY FINANCIAL DATA 105
COMPETITION 105

BIO-PATH HOLDINGS 107
KEY PERSONNEL 107
COMPANY OVERVIEW .107
KEY MILESTONES 107
PRODUCTS / TECHNOLOGIES 107
RESEARCH ACTIVITIES .109
AGREEMENTS 110
KEY FINANCIAL DATA .110
COMPETITION .111

BIOSANTE PHARMACEUTICALS INC 113
KEY PERSONNEL 113
COMPANY OVERVIEW 113
KEY MILESTONES .113
PRODUCTS / TECHNOLOGIES 114
RESEARCH ACTIVITIES 117
AGREEMENTS .120
KEY FINANCIAL DATA 121
COMPETITION 121

CALANDO PHARMACEUTICALS .123
KEY PERSONNEL 123
COMPANY OVERVIEW .123
KEY MILESTONES 123
PRODUCTS / TECHNOLOGIES 123
RESEARCH ACTIVITIES .125
AGREEMENTS .125
KEY FINANCIAL DATA 126

CAMURUS AB 127
KEY PERSONNEL 127
COMPANY OVERVIEW .127
KEY MILESTONES 127
PRODUCTS / TECHNOLOGIES 128
RESEARCH ACTIVITIES .130
AGREEMENTS .131
KEY FINANCIAL DATA 131

CAREFUSION .133
KEY PERSONNEL 133
COMPANY OVERVIEW .133
KEY MILESTONES 133
PRODUCTS 134
AGREEMENTS .137
KEY FINANCIAL DATA 138
COMPETITION 139

CELATOR PHARMACEUTICALS INC 141
KEY PERSONNEL 141
COMPANY OVERVIEW .141
KEY MILESTONES 141
PRODUCTS / TECHNOLOGIES 142
RandD ACTIVITIES 143
AGREEMENTS .145
KEY FINANCIAL DATA 145

CELL THERAPEUTICS INC 147
KEY PERSONNEL 147
COMPANY OVERVIEW .147
KEY MILESTONES 147
PRODUCTS / TECHNOLOGIES 148
RESEARCH ACTIVITIES .149
AGREEMENTS .151
KEY FINANCIAL DATA 152

CEPHALON .153
KEY PERSONNEL 153
COMPANY OVERVIEW .153
KEY MILESTONES 153
PRODUCTS 154
RandD ACTIVITIES 155
AGREEMENTS .157
KEY FINANCIAL DATA 159
COMPETITION 159

CIPHER PHARMACEUTICALS 161
KEY PERSONNEL 161
COMPANY OVERVIEW .161
KEY MILESTONES 161
PRODUCTS/TECHNOLOGIES 162
RandD MILESTONES 163
AGREEMENTS .163
KEY FINANCIAL DATA 164

COLUMBIA LABORATORIES INC 165
KEY PERSONNEL 165
COMPANY OVERVIEW .165
KEY MILESTONES 165
PRODUCTS / TECHNOLOGIES .166
RESEARCH ACTIVITIES .167
AGREEMENTS .168
KEY FINANCIAL DATA 169
COMPETITION 170

CONSORT MEDICAL PLC 171
KEY PERSONNEL 171
COMPANY OVERVIEW .171
KEY MILESTONES 171
PRODUCTS / TECHNOLOGIES 171
RESEARCH ACTIVITIES .173
AGREEMENTS .173
KEY FINANCIAL DATA .174
COMPETITION .174

CORNERSTONE THERAPEUTICS .175
KEY PERSONNEL 175
COMPANY OVERVIEW .175
KEY MILESTONES 175
PRODUCTS 176
RESEARCH ACTIVITIES .177
AGREEMENTS .177
KEY FINANCIAL DATA 179

CYTIMMUNE SCIENCES .181
KEY PERSONNEL 181
COMPANY OVERVIEW .181
PRODUCTS / TECHNOLOGIES 181
RESEARCH ACTIVITIES .182
AGREEMENTS .182
KEY FINANCIAL DATA 182
COMPETITION 183

DEBIOPHARM SA 185
KEY PERSONNEL 185
COMPANY OVERVIEW .185
KEY MILESTONES 185
PRODUCTS / TECHNOLOGIES 186
RESEARCH ACTIVITIES 187
AGREEMENTS .189
KEY FINANCIAL DATA 190
ASSOCIATED COMPANIES 190

DELCATH SYSTEMS INC .191
KEY PERSONNEL 191
COMPANY OVERVIEW .191
KEY MILESTONES 191
TECHNOLOGIES 192
RESEARCH ACTIVITIES .193
AGREEMENTS .195
KEY FINANCIAL DATA 196
COMPETITION 196

DEPOMED INC .197
KEY PERSONNEL 197
COMPANY OVERVIEW .197
KEY MILESTONES 197
PRODUCTS / TECHNOLOGIES 198
RESEARCH ACTIVITIES .199
AGREEMENTS .200
KEY FINANCIAL DATA 202
COMPETITION 202

DURECT CORPORATION 203
KEY PERSONNEL 203
COMPANY OVERVIEW .203
KEY MILESTONES 203
PRODUCTS / TECHNOLOGIES 204
AGREEMENTS .208
KEY FINANCIAL DATA 210
ASSOCIATED COMPANIES 210
COMPETITION 210

DUSA PHARMACEUTICALS INC 211
KEY PERSONNEL 211
COMPANY OVERVIEW 211
PRODUCTS / TECHNOLOGIES 211
RESEARCH ACTIVITIES 212
AGREEMENTS .213
KEY FINANCIAL DATA 214
COMPETITION 215

ECHO THERAPEUTICS .217
KEY PERSONNEL 217
COMPANY OVERVIEW .217
KEY MILESTONES 217
PRODUCTS / TECHNOLOGIES 217
RESEARCH ACTIVITIES .219
AGREEMENTS .220
KEY FINANCIAL DATA 221
COMPETITION 221

ELITE PHARMACEUTICALS INC .223
KEY PERSONNEL 223
COMPANY OVERVIEW .223
KEY MILESTONES 223
PRODUCTS / TECHNOLOGIES 224
RESEARCH ACTIVITIES .224
AGREEMENTS .225
KEY FINANCIAL DATA 226
COMPETITION 226

EGEN INC 227
KEY PERSONNEL 227
COMPANY OVERVIEW .227
PRODUCTS/TECHNOLOGIES 227
RESEARCH ACTIVITIES .228
AGREEMENTS .229
KEY FINANCIAL DATA 230

EMISPHERE TECHNOLOGIES INC . 231
KEY PERSONNEL 231
COMPANY OVERVIEW .231
KEY MILESTONES 231
PRODUCTS / TECHNOLOGIES 231
AGREEMENTS .235
KEY FINANCIAL DATA 235
COMPETITION 236

ENCAP DRUG DELIVERY 237
KEY PERSONNEL 237
COMPANY OVERVIEW .237
PRODUCTS / TECHNOLOGIES 237
AGREEMENTS .238
KEY FINANCIAL DATA 239

ENDO HEALTH SOLUTIONS 241
KEY PERSONNEL 241
COMPANY OVERVIEW .241
KEY MILESTONES 241
TECHNOLOGIES/PRODUCTS .242
RandD MILESTONES (Endo) 247
AGREEMENTS .249
AGREEMENTS (Penwest) 250
COMPETITION 251
KEY FINANCIAL DATA 251

ENDOCYTE 253
KEY PERSONNEL 253
COMPANY OVERVIEW .253
KEY MILESTONES 253
PRODUCTS / TECHNOLOGIES 254
RESEARCH ACTIVITIES .255
AGREEMENTS .257
KEY FINANCIAL DATA 257

ENZON INC 259
KEY PERSONNEL 259
COMPANY OVERVIEW .259
KEY MILESTONES 259
PRODUCTS / TECHNOLOGIES 260
RESEARCH ACTIVITIES .261
AGREEMENTS .264
KEY FINANCIAL DATA 264
COMPETITION 264

EPEIUS BIOTECHNOLOGIES INC 267
KEY PERSONNEL 267
COMPANY OVERVIEW .267
KEY MILESTONES 267
PRODUCTS/TECHNOLOGIES 268
RESEARCH ACTIVITIES .269
KEY FINANCIAL DATA 270
COMPETITION 270

ETHYPHARM S/A 273
KEY PERSONNEL 273
COMPANY OVERVIEW .273
KEY MILESTONES 273
PRODUCTS / TECHNOLOGIES 273
RESEARCH ACTIVITIES .276
AGREEMENTS .276
KEY FINANCIAL DATA 277

FLAMEL TECHNOLOGIES INC .279
KEY PERSONNEL 279
COMPANY OVERVIEW .279
KEY MILESTONES 279
PRODUCTS / TECHNOLOGIES 279
RandD ACTIVITIES 282
AGREEMENTS .283
KEY FINANCIAL DATA 284
COMPETITION 284

FZIOMED INC 285
KEY PERSONNEL 285
COMPANY OVERVIEW .285
KEY MILESTONES 285
PRODUCTS / TECHNOLOGIES 286
RESEARCH ACTIVITIES .287
KEY FINANCIAL DATA 288

GENEREX BIOTECHNOLOGY CORPORATION .289
KEY PERSONNEL 289
COMPANY OVERVIEW .289
KEY MILESTONES 289
PRODUCTS / TECHNOLOGIES 290
RESEARCH ACTIVITIES .291
AGREEMENTS .295
KEY FINANCIAL DATA 297
COMPETITION 297

GENVEC 299
KEY PERSONNEL 299
COMPANY OVERVIEW .299
KEY MILESTONES 299
PRODUCTS / TECHNOLOGIES 299
RESEARCH ACTIVITIES .300
AGREEMENTS .301
KEY FINANCIAL DATA 302
COMPETITION 302

GILEAD SCIENCES .303
KEY PERSONNEL 303
COMPANY OVERVIEW .303
KEY MILESTONES 303
PRODUCTS / TECHNOLOGIES 304
RESEARCH ACTIVITIES .307
AGREEMENTS .313
KEY FINANCIAL DATA 315

HOSPIRA .317
KEY PERSONNEL 317
COMPANY OVERVIEW .317
KEY MILESTONES 317
PRODUCTS / TECHNOLOGIES 318
RESEARCH ACTIVITIES .322
AGREEMENTS .323
KEY FINANCIAL DATA 324

IMMUNOGEN 325
KEY PERSONNEL 325
COMPANY OVERVIEW .325
KEY MILESTONES 325
PRODUCTS / TECHNOLOGIES 325
RESEARCH ACTIVITIES .326
AGREEMENTS .329
KEY FINANCIAL DATA 330

IMPAX LABORATORIES 331
KEY PERSONNEL 331
COMPANY OVERVIEW .331
KEY MILESTONES 331
PRODUCTS / TECHNOLOGIES 332
RESEARCH ACTIVITIES .334
AGREEMENTS .335
KEY FINANCIAL DATA 337
COMPETITION 337

INNOCOLL TECHNOLOGIES .339
KEY PERSONNEL 339
COMPANY OVERVIEW .339
KEY MILESTONES 339
PRODUCTS / TECHNOLOGIES 340
RESEARCH ACTIVITIES .342
AGREEMENTS .344
KEY FINANCIAL DATA 344

INOVIO PHARMACEUTICALS 345
KEY PERSONNEL 345
COMPANY OVERVIEW .345
KEY MILESTONES 345
TECHNOLOGIES / PRODUCTS 345
RESEARCH ACTIVITIES .346
AGREEMENTS .350
KEY FINANCIAL DATA 352
KEY COMPETITION .352

INSITE VISION INC 353
KEY PERSONNEL 353
COMPANY OVERVIEW .353
KEY MILESTONES 353
PRODUCTS / TECHNOLOGIES 353
RESEARCH ACTIVITIES .356
AGREEMENTS .358
KEY FINANCIAL DATA 359
COMPETITION 359

INSYS THERAPEUTICS .361
KEY PERSONNEL 361
COMPANY OVERVIEW .361
KEY MILESTONES 361
PRODUCTS / TECHNOLOGIES 362
AGREEMENTS .364
KEY FINANCIAL DATA 364

INTELGENX CORPORATION .365
KEY PERSONNEL 365
COMPANY OVERVIEW .365
KEY MILESTONES 365
PRODUCTS / TECHNOLOGIES 366
RESEARCH ACTIVITIES .367
AGREEMENTS .368
KEY FINANCIAL DATA 370
COMPETITION 370

INTERCELL AG . 371
KEY PERSONNEL 371
COMPANY OVERVIEW .371
KEY MILESTONES 371
PRODUCTS / TECHNOLOGIES 372
RESEARCH ACTIVITIES 373
AGREEMENTS 376
KEY FINANCIAL DATA 377
COMPETITION 377

LAVIPHARM GROUP 379
KEY PERSONNEL 379
COMPANY OVERVIEW .379
KEY MILESTONES 379
PRODUCTS / TECHNOLOGIES 379
AGREEMENTS .381
KEY FINANCIAL DATA 382

LIGHT SCIENCES ONCOLOGY .383
KEY PERSONNEL 383
COMPANY OVERVIEW .383
PRODUCTS / TECHNOLOGIES 383
RESEARCH ACTIVITIES .384
AGREEMENTS .386
KEY FINANCIAL DATA 386

MANNKIND CORPORATION 387
KEY PERSONNEL 387
COMPANY OVERVIEW .387
KEY MILESTONES 387
PRODUCTS / TECHNOLOGIES 388
RESEARCH ACTIVITIES .390
AGREEMENTS .393
KEY FINANCIAL DATA 394
COMPETITION 394

MARINA BIOTECH 397
KEY PERSONNEL 397
COMPANY OVERVIEW .397
KEY MILESTONES 397
PRODUCTS / TECHNOLOGIES 398
RESEARCH ACTIVITIES .400
AGREEMENTS .403
KEY FINANCIAL DATA 405
COMPETITION 405

MEDIMMUNE INC .407
KEY PERSONNEL 407
COMPANY OVERVIEW .407
KEY MILESTONES 407
PRODUCTS / TECHNOLOGIES 408
RESEARCH ACTIVITIES .409
AGREEMENTS .410
KEY FINANCIAL DATA .411
COMPETITION 412

MILESTONE SCIENTIFIC .413
KEY PERSONNEL 413
COMPANY BACKGROUND 413
KEY MILESTONES 413
PRODUCTS / TECHNOLOGIES 413
AGREEMENTS .415
KEY FINANCIAL DATA 416
COMPETITION 417

MOOG MEDICAL DEVICES .419
KEY PERSONNEL 419
COMPANY OVERVIEW .419
KEY MILESTONES 419
PRODUCTS / TECHNOLOGIES 419
AGREEMENTS .420
KEY FINANCIAL DATA 421

NANOBIOTIX 423
KEY PERSONNEL 423
COMPANY OVERVIEW .423
PRODUCTS / TECHNOLOGIES 423
RESEARCH ACTIVITIES .424
AGREEMENTS .424
KEY FINANCIAL DATA 425

NANOBIO CORPORATION .427
KEY PERSONNEL 427
COMPANY OVERVIEW .427
KEY MILESTONES 427
PRODUCTS / TECHNOLOGIES 427
RESEARCH ACTIVITIES .428
AGREEMENTS .430
KEY FINANCIAL DATA 431

NANOCARRIER 433
KEY PERSONNEL 433
COMPANY OVERVIEW .433
PRODUCTS / TECHNOLOGIES 433
RESEARCH ACTIVITIES .434
AGREEMENTS .435
KEY FINANCIAL DATA 437

NANOTHERAPEUTICS INC 439
KEY PERSONNEL 439
COMPANY OVERVIEW .439
KEY MILESTONES 439
PRODUCTS / TECHNOLOGIES 440
RESEARCH ACTIVITIES .443
AGREEMENTS .445
KEY FINANCIAL DATA 445

NEKTAR THERAPEUTICS 447
KEY PERSONNEL 447
COMPANY OVERVIEW .447
KEY MILESTONES 447
PRODUCTS / TECHNOLOGIES 448
RESEARCH ACTIVITIES .449
AGREEMENTS .454
KEY FINANCIAL DATA 455
ASSOCIATED COMPANIES 455
COMPETITION 456

NEUROGESX .457
KEY PERSONNEL 457
COMPANY OVERVIEW .457
KEY MILESTONES 457
PRODUCTS / TECHNOLOGIES 458
RESEARCH STRATEGY 458
AGREEMENTS .459
KEY FINANCIAL DATA 459
COMPETITION 459

NOVADEL PHARMA .461
KEY PERSONNEL 461
COMPANY OVERVIEW .461
KEY MILESTONES 461
PRODUCTS / TECHNOLOGIES 461
RESEARCH ACTIVITIES .462
AGREEMENTS .464
KEY FINANCIAL DATA 465
COMPETITION 465

NOVEN PHARMACEUTICALS 467
KEY PERSONNEL 467
COMPANY OVERVIEW .467
KEY MILESTONES 467
PRODUCTS / TECHNOLOGIES 468
RESEARCH ACTIVITIES .469
AGREEMENTS .470
KEY FINANCIAL DATA 470
COMPETITION 471

OCTOPLUS .473
KEY PERSONNEL 473
COMPANY OVERVIEW .473
KEY MILESTONES 473
PRODUCTS / TECHNOLOGIES 473
AGREEMENTS .476
KEY FINANCIAL DATA 478

OREXO 479
KEY PERSONNEL 479
COMPANY OVERVIEW .479
KEY MILESTONES 479
PRODUCTS / TECHNOLOGIES 481
RESEARCH ACTIVITIES .483
AGREEMENTS .487
KEY FINANCIAL DATA 488
COMPETITION 488

OTSUKA HOLDINGS 489
KEY PERSONNEL 489
COMPANY OVERVIEW .489
KEY MILESTONES 489
PRODUCTS / TECHNOLOGIES 490
RESEARCH ACTIVITIES .494
AGREEMENTS 497
KEY FINANCIAL DATA 498

PACIRA PHARMACEUTICALS INC .501
KEY PERSONNEL 501
COMPANY OVERVIEW .501
KEY MILESTONES 501
PRODUCTS / TECHNOLOGIES 502
RESEARCH ACTIVITIES .503
AGREEMENTS .505
KEY FINANCIAL DATA 506
COMPETITION 506

PCI BIOTECH 507
KEY PERSONNEL 507
COMPANY OVERVIEW .507
KEY MILESTONES 507
PRODUCTS / TECHNOLOGIES 507
RESEARCH ACTIVITIES .508
AGREEMENTS .509
KEY FINANCIAL DATA 509

PEARL THERAPEUTICS 511
KEY PERSONNEL 511
COMPANY OVERVIEW 511
PRODUCTS / TECHNOLOGIES 511
RESEARCH STRATEGY 513
KEY FINANCIAL DATA 515

PHOSPHAGENICS LIMITED 517
KEY PERSONNEL 517
COMPANY OVERVIEW .517
KEY MILESTONES 517
TECHNOLOGIES / PRODUCTS 517
RESEARCH ACTIVITIES .520
AGREEMENTS .521
FINANCIALS .522

PHOTOCURE ASA .523
KEY PERSONNEL 523
COMPANY OVERVIEW .523
KEY MILESTONES 523
PRODUCTS / TECHNOLOGIES 524
RESEARCH ACTIVITIES .525
AGREEMENTS .528
KEY FINANCIAL DATA 528
ASSOCIATED COMPANIES 528

POLYTHERICS LTD 529
KEY PERSONNEL 529
COMPANY OVERVIEW .529
KEY MILESTONES 529
PRODUCTS / TECHNOLOGIES 529
AGREEMENTS .531
KEY FINANCIAL DATA 533

pSIVIDA 535
KEY PERSONNEL 535
COMPANY OVERVIEW .535
KEY MILESTONES 535
TECHNOLOGIES / PRODUCTS 536
RESEARCH ACTIVITIES .537
AGREEMENTS .540
KEY FINANCIAL DATA 542
COMPETITION 542

QLT 543
KEY PERSONNEL 543
COMPANY OVERVIEW .543
KEY MILESTONES 543
PRODUCTS / TECHNOLOGIES 544
RESEARCH ACTIVITIES .545
AGREEMENTS .547
KEY FINANCIAL DATA 548
COMPETITION 548

QUEST PHARMATECH .551
KEY PERSONNEL 551
COMPANY OVERVIEW .551
KEY MILESTONES 551
PRODUCTS / TECHNOLOGIES 551
RESEARCH ACTIVITIES .552
AGREEMENTS .553
KEY FINANCIAL DATA 554

RAPTOR PHARMACEUTICALS 555
KEY PERSONNEL 555
COMPANY OVERVIEW .555
KEY MILESTONES 555
PRODUCTS / TECHNOLOGIES 556
RESEARCH ACTIVITIES .558
AGREEMENTS .562
KEY FINANCIAL DATA 563
COMPETITION 563

RETRACTABLE TECHNOLOGIES INC 567
KEY PERSONNEL 567
COMPANY OVERVIEW .567
PRODUCTS / TECHNOLOGIES 567
AGREEMENTS .569
LITIGATION UPDATE 569
KEY FINANCIAL DATA 569
COMPETITION 569

SAVARA PHARMACEUTICALS INC 571
KEY PERSONNEL 571
COMPANY OVERVIEW .571
KEY MILESTONES 571
PRODUCTS / TECHNOLOGIES 571
RESEARCH ACTIVITIES .572
KEY FINANCIAL DATA 572

SCOLR PHARMA INC 573
KEY PERSONNEL 573
COMPANY OVERVIEW .573
KEY MILESTONES 573
PRODUCTS / TECHNOLOGIES 573
RESEARCH ACTIVITIES .574
AGREEMENTS 575
KEY FINANCIAL DATA 576
COMPETITION 576

SEATTLE GENETICS .577
KEY PERSONNEL 577
COMPANY OVERVIEW .577
KEY MILESTONES 577
PRODUCTS / TECHNOLOGIES 578
RESEARCH ACTIVITIES .579
AGREEMENTS .583
KEY FINANCIAL DATA 584
COMPETITION 585

SILENCE THERAPEUTICS 587
KEY PERSONNEL 587
COMPANY OVERVIEW .587
PRODUCTS / TECHNOLOGIES 587
RESEARCH ACTIVITIES .588
AGREEMENTS .590
KEY FINANCIAL DATA 591

SKINVISIBLE INC 593
KEY PERSONNEL 593
COMPANY OVERVIEW .593
KEY MILESTONES 593
PRODUCTS / TECHNOLOGIES 593
RESEARCH ACTIVITIES .594
AGREEMENTS .596
KEY FINANCIAL DATA 597
COMPETITION 597

SKYEPHARMA PLC 599
KEY PERSONNEL 599
COMPANY OVERVIEW .599
KEY MILESTONES 599
PRODUCTS / TECHNOLOGIES 601
RESEARCH ACTIVITIES .606
AGREEMENTS .608
KEY FINANCIAL DATA 609
ASSOCIATED COMPANIES 609
COMPETITION 609

SOLIGENIX .611
KEY PERSONNEL 611
COMPANY OVERVIEW 611
KEY MILESTONES .611
PRODUCTS / TECHNOLOGIES 612
RESEARCH ACTIVITIES .615
AGREEMENTS .618
KEY FINANCIAL DATA 619
COMPETITION 619

STARPHARMA . 621
KEY PERSONNEL 621
COMPANY OVERVIEW .621
KEY MILESTONES 621
PRODUCTS / TECHNOLOGIES 621
RESEARCH ACTIVITIES .622
AGREEMENTS .625
KEY FINANCIAL DATA 626

SUPRATEK PHARMA INC 627
KEY PERSONNEL 627
COMPANY OVERVIEW .627
KEY MILESTONES 627
PRODUCTS / TECHNOLOGIES 627
RESEARCH ACTIVITIES .630
KEY FINANCIAL DATA 630

TEKMIRA PHARMACEUTICALS CORPORATION .631
KEY PERSONNEL 631
COMPANY OVERVIEW .631
KEY MILESTONES 631
PRODUCTS / TECHNOLOGIES 632
RESEARCH ACTIVITIES .635
AGREEMENTS .638
KEY FINANCIAL DATA 640

TOCAGEN 641
KEY PERSONNEL 641
COMPANY OVERVIEW .641
PRODUCTS / TECHNOLOGIES 641
RESEARCH ACTIVITIES .643
AGREEMENTS .643
KEY FINANCIAL DATA 643
COMPETITION 643

TRIMEL PHARMACEUTICALS .645
KEY PERSONNEL 645
COMPANY OVERVIEW .645
KEY MILESTONES 645
PRODUCTS / TECHNOLOGIES .645
RESEARCH ACTIVITIES .647
KEY FINANCIAL DATA 649
COMPETITION 649

UNILIFE 651
KEY PERSONNEL 651
COMPANY OVERVIEW .651
KEY MILESTONES 651
PRODUCTS / TECHNOLOGIES 652
RESEARCH ACTIVITIES .653
AGREEMENTS .654
KEY FINANCIAL DATA 655
COMPETITION 655

VALEANT PHARMACEUTICALS .657
KEY PERSONNEL 657
COMPANY OVERVIEW .657
KEY MILESTONES 657
PRODUCTS / TECHNOLOGIES .658
RESEARCH ACTIVITIES .662
AGREEMENTS 663
KEY FINANCIAL DATA 666
COMPETITION 666

VECTURA LTD .669
KEY PERSONNEL 669
COMPANY OVERVIEW .669
KEY MILESTONES 669
PRODUCTS / TECHNOLOGIES 670
RESEARCH ACTIVITIES .672
AGREEMENTS .675
KEY FINANCIAL DATA 676
ASSOCIATED COMPANIES 676

VICAL INC 677
KEY PERSONNEL 677
COMPANY OVERVIEW .677
KEY MILESTONES 677
PRODUCTS / TECHNOLOGIES 677
RESEARCH ACTIVITIES .678
AGREEMENTS .681
KEY FINANCIAL DATA 683

VIVUS INC 685
KEY PERSONNEL 685
COMPANY OVERVIEW .685
KEY MILESTONES 685
PRODUCTS / TECHNOLOGIES 686
RESEARCH ACTIVITIES .690
AGREEMENTS .691
KEY FINANCIAL DATA 691
COMPETITION 691

ZOGENIX INC 693
KEY PERSONNEL 693
COMPANY OVERVIEW .693
KEY MILESTONES 693
PRODUCTS / TECHNOLOGIES 694
RESEARCH ACTIVITIES .695
AGREEMENTS .696
KEY FINANCIAL DATA 697

ZOSANO PHARMA 699
KEY PERSONNEL 699
COMPANY OVERVIEW .699
PRODUCTS / TECHNOLOGIES 699
RESEARCH ACTIVITIES .700
AGREEMENTS .701
KEY FINANCIAL DATA 701

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Pulmonary Drug Delivery Systems: Technologies and Global Markets

Pulmonary Drug Delivery Systems: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Receive a detailed analysis of the present and future global market for pulmonary drug delivery technologies. - Receive information on pulmonary drug delivery technologies currently ...

RNAi Drug Delivery : Technologies and Gobal Markets

RNAi Drug Delivery : Technologies and Gobal Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides an in-depth assessment of recent progress and future opportunities for RNA interference (RNAi) players in major therapeutic and drug delivery areas, including infectious ...

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

nebulizer is a medical device used for the treatment of respiratory disorders (asthma, COPD and cystic fibrosis) that converts liquid medication into mist or aerosol. Thus, the medicine can easily reach ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.